Beijing SL Pharmaceutical Co Ltd operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing SL Pharmaceutical Co Ltd with three other
companies in this sector in China:
Zhongyuan Union Cell & Gene Engineering Corp Ltd
sales of 835.64 million Chinese Renmimbi [US$126.92 million]
of which 61%
was Scientific research service),
Boya Bio-pharmaceutical Group Co Ltd
(946.57 million Chinese Renmimbi [US$143.77 million]
of which 56%
was Blood Plasma), and
Tianjin Ringpu Bio-Technology Co Ltd
(969.68 million Chinese Renmimbi [US$147.28 million]
of which 63%
was Veterinary Biological Products).
Beijing SL Pharmaceutical Co Ltd reported sales of 1.01 billion Chinese Renmimbi (US$153.38 million)
December of 2016.
decrease of 12.7%
versus 2015, when the company's sales were 1.16 billion Chinese Renmimbi.
Contributing to the drop in overall sales was the 32.7% decline
in Other Operating, from 27.28 million Chinese Renmimbi to 18.37 million Chinese Renmimbi.
There were also decreases in sales in
Pharmaceuticals Industry (down 12.2% to 991.48 million Chinese Renmimbi)